Company / EPS (Diluted)
AGIOS PHARMACEUTICALS, INC. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$6.33
FY2025
5-year range
-$6.33 / $26.55
FY2021-FY2025
Trend
-49.6%
vs FY2024
Sector context
#189 of 204
Health Care
What the data says
Among 204 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 7% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-6.75 in FY2019 to $26.55 in FY2023.
Based on SEC 10-K filings.
-6.33 in FY2025.
Declined from $26.55 to $-6.33 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 204This company -$6.33 Sector average -$0.98
▼
-546.2% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 49.6% year-over-year.
- Ranks #189 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.33 | -49.6% |
| FY2024 | -$4.23 | -115.9% |
| FY2023 | $26.55 | +660.1% |
| FY2022 | -$4.74 | -117.9% |
| FY2021 | $26.55 | +540.3% |
| FY2020 | -$6.03 | +10.7% |
| FY2019 | -$6.75 | -33.1% |
| FY2018 | -$5.07 | -61.0% |
| FY2017 | -$3.15 | -98.1% |
| FY2016 | -$1.59 | +43.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026